Innovative drug out-licensing deal value (half year)

STO-REC-STATPZ26BJT1 Official
100 billionUSD

China · as of 30 Jun 2026

Innovative drug out-licensing deal value in China (half year) stood at 100 billion USD as of 30 June 2026 (State Council).

Original source
Publisher
State Council
Authority tier
T1 Official
Locator
China to expand health insurance coverage for innovative drugs
Retrieved
17 Sep 2026
Status
Verified

What the source says

In the first half of 2026, the total value of China's innovative drug out-licensing deals reached a record high of more than 100 billion U.S. dollars, according to the Ministry of Industry and Information Technology.

Verbatim extraction verified: The figure 100 billion USD is directly attested in the quoted passage (China to expand health insurance coverage for innovative drugs).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Other sources disagree

1 record reports a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.

ValueDivergenceSource organisationDocumentLocatorDetails
110 billion USD+10.0%NHSA国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元我国上半年创新药对外授权约1100亿美元 创历史新高Open record

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
State Council of China. (2026). China to expand health insurance coverage for innovative drugs. Retrieved September 17, 2026, from https://english.www.gov.cn/news/202609/04/content_WS6a9a7481c6d00ca5f9a0d02f.html. Via StatOrigin, https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF
MLA
State Council of China. "China to expand health insurance coverage for innovative drugs." 2026, https://english.www.gov.cn/news/202609/04/content_WS6a9a7481c6d00ca5f9a0d02f.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF.
Chicago
State Council of China. "China to expand health insurance coverage for innovative drugs." 2026. https://english.www.gov.cn/news/202609/04/content_WS6a9a7481c6d00ca5f9a0d02f.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF.
BibTeX
@misc{statecouncil2026innovative6ytahf, author = {{State Council of China}}, title = {China to expand health insurance coverage for innovative drugs}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF}, note = {Original source: https://english.www.gov.cn/news/202609/04/content\_WS6a9a7481c6d00ca5f9a0d02f.html. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATPZ26BJ T1 Official

Primary Source

Publisher
State Council of China · homepage ↗
Authority tier
Tier 1 · Multilateral Official
Report
China to expand health insurance coverage for innovative drugs
Type
Press release
Published
Locator
China to expand health insurance coverage for innovative drugs
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF